Fractyl Health(GUTS) - 2024 Q1 - Quarterly Results

Initiation of Remain-1 pivotal study for weight maintenance in patients with obesity after discontinuation of GLP-1 based drugs expected in the second half of 2024 Topline data from Revitalize-1 pivotal study in patients with inadequately controlled T2D anticipated in the fourth quarter 2024 Update from real-world Germany registry study of Revita in patients with T2D at DDG Annual Meeting Exhibit 99.1 Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates Appointed Adrian ...